Triamterene and Hydrochlorothiazide
- Product NDC
- 43063-424
- 11-digit product format
- 430630424
- Labeler code
- 43063
- Product ID
- 43063-424_de9ad048-8a7f-4c23-e053-2995a90ad527
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Triamterene and Hydrochlorothiazide
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- PD-Rx Pharmaceuticals, Inc.
- Application
- NDA019129
- Marketing category
- NDA
- Marketing start
- 1996-09-16
- Marketing end
- 2022-07-31
- Substance
- HYDROCHLOROTHIAZIDE; TRIAMTERENE
- Active strength
- 25 mg/1; mg/1
- Pharmacologic classes
- Decreased Renal K+ Excretion [PE], Increased Diuresis [PE], Increased Diuresis [PE], Potassium-sparing Diuretic [EPC], Thiazide Diuretic [EPC], Thiazides [CS]
- NDC exclude flag
- No
- Listing certified through
- 0000-00-00
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 43063-424-30 | 43063042430 | 30 TABLET in 1 BOTTLE, PLASTIC (43063-424-30) | 30 tablet | 2013-01-24 | 0000-00-00 | No | No | Current |
| 43063-424-90 | 43063042490 | 90 TABLET in 1 BOTTLE, PLASTIC (43063-424-90) | 90 tablet | 2013-01-24 | 0000-00-00 | No | No | Current |